![](/img/cover-not-exists.png)
Maximum-tolerated dose defined for single-agent gemcitabine: a phase I dose-escalation study in chemotherapy-naive patients with advanced non-small-cell lung cancer.
Fossella, F V, Lippman, S M, Shin, D M, Tarassoff, P, Calayag-Jung, M, Perez-Soler, R, Lee, J S, Murphy, W K, Glisson, B, Rivera, E, Hong, W KVolume:
15
Language:
english
Journal:
Journal of Clinical Oncology
DOI:
10.1200/JCO.1997.15.1.310
Date:
January, 1997
File:
PDF, 572 KB
english, 1997